ANAL CANCER

This is an early-stage study to find a safe dose of a new drug called KFA115, both by itself and combined with an existing immunotherapy (pembrolizumab). It involves about 126 adults with various advanced cancers that have stopped responding to standard treatments. The main goal …

This early-stage trial is testing a new therapeutic vaccine designed to fight cancers caused by the human papillomavirus (HPV). Researchers want to see if the vaccine works better when given alone or combined with an immunotherapy drug called M7824. The study includes adults with…

This study is testing whether using a lower radiation dose on healthy lymph nodes can reduce treatment side effects for people with anal cancer. The trial will compare the new approach to standard radiation in 33 patients undergoing combined chemotherapy and radiation. Researcher…

This study tested pembrolizumab, an immunotherapy drug, in people with advanced solid tumors who had already tried standard treatments that stopped working. Researchers enrolled 1,609 participants with various cancers including anal, cervical, lung, and thyroid cancers to see how…

This study is testing a combination of three immunotherapy drugs for people with advanced cancers that have not responded well to standard treatments. It focuses on HPV-related cancers (like cervical, throat, and anal cancers) and certain types of colon and small bowel cancer. Th…

This study is testing whether a community program called Potlako+ can help people with possible cancer symptoms get diagnosed and treated faster. The program involves educating communities about cancer warning signs and providing patient navigators to guide people through the hea…